Steatotic liver disease: pathophysiology and emerging pharmacotherapies

M Kokkorakis, E Muzurović, Š Volčanšek… - Pharmacological …, 2024 - ASPET
Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Hepatocellular carcinoma in non-alcoholic fatty liver disease: from epidemiology to diagnostic approach

I Grgurevic, T Bozin, M Mikus, M Kukla, J O'Beirne - Cancers, 2021 - mdpi.com
Simple Summary Non-alcoholic fatty liver disease (NAFLD) is expected to become the
leading cause of hepatocellular carcinoma (HCC) in the near future. In this article, we review …

[HTML][HTML] Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma

Q Song, X Zhang, W Liu, H Wei, W Liang, Y Zhou… - Journal of …, 2023 - Elsevier
Background & Aims Recent studies have highlighted the role of the gut microbiota and their
metabolites in non-alcoholic fatty liver disease-associated hepatocellular carcinoma …

Experimental models of hepatocellular carcinoma—a preclinical perspective

A Blidisel, I Marcovici, D Coricovac, F Hut… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is characterized by a broad molecular
and genetic heterogeneity, which makes it a challenging subject in terms of the underlying …

[HTML][HTML] Национальный Консенсус для врачей по ведению взрослых пациентов с неалкогольной жировой болезнью печени и ее основными коморбидными …

МВ Маевская, ЮВ Котовская, ВТ Ивашкин… - Терапевтический …, 2022 - cyberleninka.ru
Национальный мультидисциплинарный Консенсус подготовлен при участии
Национальной медицинской Ассоциации по изучению сочетанных заболеваний …

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: Current status and therapeutic targets

Y Chen, W Wang, MP Morgan, T Robson… - Frontiers in …, 2023 - frontiersin.org
Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for
numerous cancers, including hepatocellular carcinoma (HCC), the third leading cause of …

Metabolic risk factors for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a prospective study

SO Antwi, EC Craver, YA Nartey, K Sartorius, T Patel - Cancers, 2022 - mdpi.com
Simple Summary About 30% of Americans have nonalcoholic fatty liver disease (NAFLD),
and some of these individuals may develop hepatocellular carcinoma (HCC), a frequently …

Nonalcoholic fatty liver disease-related hepatocellular carcinoma: the next threat after viral hepatitis

M Salaheldin, H Aly, L Lau, S Afify, M El-Kassas - Diagnostics, 2023 - mdpi.com
For many years, we have faced the complications of viral hepatitis and alcohol-related liver
diseases such as cirrhosis, decompensation, portal hypertension, and hepatocellular …

[HTML][HTML] Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists …

VT Ivashkin, MV Maevskaya, MS Zharkova… - Russian Journal of …, 2022 - gastro-j.ru
Aim: present clinical guidelines, aimed at general practitioners, gastroenterologists,
cardiologists, endocrinologists, comprise up-to-date methods of diagnosis and treatment of …

[HTML][HTML] Non-alcoholic fatty liver disease-related hepatocellular carcinoma

D Daher, KS El Dahan, AG Singal - Journal of Liver Cancer, 2023 - synapse.koreamed.org
Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of liver disease,
is an increasingly common cause of hepatocellular carcinoma (HCC). Several demographic …